##ANALYSISTYPE=SOMATIC_SINGLESAMPLE
##PIPELINE=megSAP 0.2-251-gf0b0a2c
##FILTER=indelError=Likely artifact due to indel reads at this position
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=str10=Less than 10% or more than 90% of variant supporting reads on one strand
##SAMPLE=<ID=TUMOR,Gender=female,ExternalSampleName=151172,IsTumor=yes,IsFFPE=yes,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_som_c=Somatic variant count in the NGSD.
##DESCRIPTION=NGSD_som_p=Project names of project containing this somatic variant in the NGSD.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group (Neoplasms).
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample TUMOR).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample TUMOR).
##DESCRIPTION=somatic_classification_comment=Somatic classification comment from the NGSD.
##DESCRIPTION=somatic_classification=Somatic classification from the NGSD.
#chr	start	end	ref	obs	tumor_af	tumor_dp	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	NGSD_som_c	NGSD_som_p	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	somatic_classification	somatic_classification_comment	validation	comment	gene_info
chr13	32890572	32890572	G	A	1.0000	63	off-target	QUAL=255	BRCA2	5'UTR	BRCA2:ENST00000380152:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000544455:5_prime_UTR_variant:MODIFIER:exon2/28:c.-26G>A::	BRCA2:NM_000059.3:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::	regulatory_region_variant:promoter	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	125965 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.2093	0.2455	836,.	0.1012,0.1908,0.3746,0.2581,0.2847	0.4990			0.13,0.34	8.11						4	PATHO_Somatic,SomaticAndTreatment	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							ZAR1L (inh=n/a oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32911888	32911888	A	G	0.9926	136		QUAL=255	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.3396A>G:p.Lys1132=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126010 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs1801406	0.2668	0.2976	1426,.	0.2282,0.2127,0.3820,0.3086,0.2989	0.2130			0.49,0.90	7.74					COSM4415776	8	Novartis,PATHO_Somatic,SomaticAndTreatment,TEST_SomaticAndTreatment	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32913055	32913055	A	G	1.0000	161		QUAL=255	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat],BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.4563A>G:p.Leu1521=:PF00634 [BRCA2 repeat]	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	132779 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206075		0.9944	15079,.	0.9257,0.9957,0.9999,0.9996,0.9999	0.0710			0.00,0.27	3.15						4	PATHO_Somatic	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32915005	32915005	G	C	1.0000	96		QUAL=255	BRCA2	synonymous	BRCA2:ENST00000380152:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000544455:synonymous_variant:LOW:exon11/28:c.6513G>C:p.Val2171=:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:	regulatory_region_variant:promoter_flanking_region	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	132780 [benign DISEASE=Hereditary breast and ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified,not provided];			rs206076		0.9942	15085,.	0.9253,0.9956,0.9999,0.9996,0.9999	-0.8750			0.02,0.13	0.12					COSM4147690	4	PATHO_Somatic	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32915411	32915414	AATT	-	0.9565	46	off-target	QUAL=235.61315282918	BRCA2	intron	BRCA2:ENST00000380152:intron_variant:MODIFIER:intron11/26:c.6841+80_6841+83del::,BRCA2:ENST00000544455:intron_variant:MODIFIER:intron11/27:c.6841+80_6841+83del::	BRCA2:NM_000059.3:intron_variant:MODIFIER:intron11/26:c.6841+80_6841+83del::	regulatory_region_variant:promoter_flanking_region	600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	126122 [benign DISEASE=Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial 2,not specified];			rs1451057775		0.2926	1331,.		0.8180				5.75						1	SomaticAndTreatment	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32929387	32929387	T	C	1.0000	119		QUAL=255	BRCA2	missense	BRCA2:ENST00000380152:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000544455:missense_variant:MODERATE:exon14/28:c.7397T>C:p.Val2466Ala:	BRCA2:NM_000059.3:synonymous_variant:LOW:exon14/27:c.7397T>C:p.Ala2466=:		600185 [GENE=BRCA2 PHENOS=Pancreatic cancer 2,613347/Breast cancer,male,susceptibility to,114480,Autosomal dominant,Somatic mutation/Glioblastoma 3,613029,Autosomal recessive/Wilms tumor,194070,Autosomal dominant,Somatic mutation/Fanconi anemia,complementation group D1,605724,Autosomal recessive/Medulloblastoma,155255,Autosomal recessive,Autosomal dominant,Somatic mutation/Prostate cancer,176807,Autosomal dominant,Somatic mutation/Breast-ovarian cancer,familial,2,612555,Autosomal dominant];	133738 [benign DISEASE=Ductal breast carcinoma,not specified];			rs169547	0.9758	0.9949	15141,.	0.9326,0.9960,0.9999,0.9997,0.9999	2.3520	T(1.00),T(1.00)	B(0.00),B(0.00)	0.00,0.10	12.33	0.09					4	PATHO_Somatic	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)							BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr17	41226536	41226536	G	T	0.4944	89		QUAL=163.55472788048	BRCA1	stop_gained&splice_region,intron,splice_region&5'UTR	BRCA1:ENST00000309486:stop_gained&splice_region_variant:HIGH:exon13/22:c.3599C>A:p.Ser1200Ter:,BRCA1:ENST00000346315:intron_variant:MODIFIER:intron12/18:c.4357+7885C>A::,BRCA1:ENST00000351666:stop_gained&splice_region_variant:HIGH:exon10/19:c.938C>A:p.Ser313Ter:,BRCA1:ENST00000352993:stop_gained&splice_region_variant:HIGH:exon13/22:c.1061C>A:p.Ser354Ter:,BRCA1:ENST00000354071:intron_variant:MODIFIER:intron12/17:c.4357+7885C>A::,BRCA1:ENST00000357654:stop_gained&splice_region_variant:HIGH:exon14/23:c.4487C>A:p.Ser1496Ter:,BRCA1:ENST00000468300:stop_gained&splice_region_variant:HIGH:exon14/22:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000471181:stop_gained&splice_region_variant:HIGH:exon15/24:c.4550C>A:p.Ser1517Ter:,BRCA1:ENST00000491747:stop_gained&splice_region_variant:HIGH:exon14/23:c.1175C>A:p.Ser392Ter:,BRCA1:ENST00000493795:stop_gained&splice_region_variant:HIGH:exon13/22:c.4346C>A:p.Ser1449Ter:,BRCA1:ENST00000586385:intron_variant:MODIFIER:intron1/7:c.5-10568C>A::,BRCA1:ENST00000591534:splice_region_variant&5_prime_UTR_variant:LOW:exon2/11:c.-41C>A::,BRCA1:ENST00000591849:intron_variant:MODIFIER:intron1/4:c.-98-24329C>A::	BRCA1:NM_007294.3:stop_gained&splice_region_variant:HIGH:exon14/23:c.4487C>A:p.Ser1496Ter:,BRCA1:NM_007297.3:stop_gained&splice_region_variant:HIGH:exon13/22:c.4346C>A:p.Ser1449Ter:,BRCA1:NM_007298.3:stop_gained&splice_region_variant:HIGH:exon13/22:c.1175C>A:p.Ser392Ter:,BRCA1:NM_007299.3:stop_gained&splice_region_variant:HIGH:exon14/22:c.1175C>A:p.Ser392Ter:,BRCA1:NM_007300.3:stop_gained&splice_region_variant:HIGH:exon15/24:c.4550C>A:p.Ser1517Ter:,BRCA1:NR_027676.1:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon14/23:n.4623C>A::		113705 [GENE=BRCA1 PHENOS=Fanconi anemia,complementation group S,617883,Autosomal recessive/Pancreatic cancer,susceptibility to,4,614320/Breast-ovarian cancer,familial,1,604370,Autosomal dominant,Multifactorial];	55215 [pathogenic DISEASE=Ovarian Neoplasms,Familial cancer of breast,Breast-ovarian cancer, familial 1];	CM1719097 [CLASS=DM MUT=ALT PHEN="Ovarian cancer" GENE=BRCA1];		rs80356953					1.1860			0.58,0.53	35.00		12.00>11.67				0		0	0	0 / 0	5	"[5] Ulrike Faust 03.06.2015"					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
